María Ángeles Núñez Sánchez

I completed my PhD in the Group on Quality, Safety, and Bioactivity of Plant Foods at CEBAS-CSIC (Murcia). My project focused on the effects of urolithins, microbial-derived metabolites from pomegranate, on colorectal cancer. After obtaining my PhD with highest honors in 2016, I joined the Bile Acid group at APC Microbiome Ireland (University College Cork, Cork, Ireland). There, I received a Marie-Curie Postdoctoral Fellowship to study the role of secondary bile acids in gut development during early infancy and their implications for health later in life. I also spent time at the Center for Research in Vascular Biology, working on the development of synbiotic strategies to prevent metabolic syndrome.

In 2022, I returned to Murcia to work at the Biomedical Research Institute of Murcia (IMIB), where my research focuses on the study of the gut microbiota and its associated metabolites, examining their influence on various metabolic disorders. I am currently the grantee of a 'Stop Fuga de Cerebros' contract funded by Roche and conduct my own research as a Principal Investigator, funded by the Fundación Séneca. My research explores the relationship between the metabolome, epigenome, and microbiome in the mother-infant axis, with a specific focus on childhood obesity and predisposition to different metabolic diseases.